TROY FULTON: Open Payments
NPI 1053937599 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,082 in 83 payments from 15 companies in 2025. Trend: 2023 $2,867 · 2024 $2,329 · 2025 $2,082
Food & beverage: $2,082
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $645 |
| Otsuka America Pharmaceutical, Inc. | 6 | $220 |
| Corium, LLC | 12 | $207 |
| Teva Pharmaceuticals USA, Inc. | 5 | $205 |
| E.R. Squibb & Sons, L.L.C. | 4 | $172 |
| Alkermes, Inc. | 5 | $122 |
| Vanda Pharmaceuticals Inc. | 5 | $102 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $86 |
| Lundbeck LLC | 3 | $74 |
| Biogen, Inc. | 2 | $53 |
Products named: VRAYLAR, Azstarys, COBENFY, REXULTI, UZEDY, ABILIFY MAINTENA, FANAPT, CAPLYTA.
Industry payments across AZ — which companies pay providers there.
